Valuation check: AFMD's profit margin is -7978.34%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2024
Trailing 12 months ending Sep 2024
The latest profit margin for AFMD is -7978.34% as of September 2024. That compares with -643.86% in the prior-year period — down 1139.1% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Affimed N.V.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, AFMD's profit margin moved from -643.86% to -7978.34% — a 1139.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Affimed N.V.'s valuation or profitability profile.
Against Healthcare companies, AFMD currently prints -7978.34% for profit margin, while the sector average sits near 13.89%. That is roughly 57526.7% below the sector mean. Large gaps often invite a closer look at Affimed N.V.'s growth, margins, and balance sheet.
Profit Margin shows how effectively Affimed N.V. converts resources into returns. At -7978.34%, AFMD may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -643.86% in the prior-year period — down 1139.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting AFMD's profit margin (-7978.34%), review year-over-year change from -643.86%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.